Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?

被引：0
|
作者：
Claire L. Jansson-Knodell
Courtney E. Harris
Edward V. Loftus
Randall C. Walker
Mark J. Enzler
Abinash Virk
机构：
[1] Indiana University,Division of Gastroenterology and Hepatology
[2] Mayo Clinic,Department of Internal Medicine
[3] Mayo Clinic,Division of Gastroenterology and Hepatology
[4] Mayo Clinic,Division of Infectious Diseases
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Fungal infection; Infliximab; Adalimumab; Certolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：190 / 198
页数：8
相关论文
共 50 条
  • [21] Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure
    Yan Jiang
    Oliver Lin
    Sidhartha R. Sinha
    Digestive Diseases and Sciences, 2017, 62 : 1597 - 1606
  • [22] Incidence and Risk Factors for Invasive Fungal Infections in Patients Initiating Tumor Necrosis Factor-Alpha Inhibitors for Inflammatory Bowel Disease and Rheumatoid Arthritis
    Hennessee, Ian
    Benedict, Kaitlin
    Bahr, Nathan C.
    Lipner, Shari R.
    Gold, Jeremy A. W.
    CLINICAL INFECTIOUS DISEASES, 2024, 80 (02) : 364 - 366
  • [23] TREATMENT OF INFLAMMATORY BOWEL-DISEASE USING ANTITUMOR NECROSIS FACTOR-ALPHA ANTIBODY
    WATKINS, PE
    FOULKES, R
    STEPHENS, S
    WARD, P
    WARREN, BF
    BRITISH JOURNAL OF SURGERY, 1995, 82 (05) : 693 - 694
  • [24] Tumor necrosis factor-alpha concentrations in whole gut lavage fluid do not represent disease activity in inflammatory bowel disease
    Krumm, PJJM
    vanDijk, APM
    Tak, CJAM
    Zijlstra, FJ
    vanBlankenstein, M
    Wilson, JHP
    GASTROENTEROLOGY, 1996, 110 (04) : A942 - A942
  • [25] Cutaneous pseudolymphoma induced by tumor necrosis factor-alpha inhibitors
    Yokota, Masaki
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : E217 - E219
  • [26] Bradypnea in a child taking tumor necrosis factor-alpha inhibitors
    Sener, Seher
    Basaran, Ozge
    Bilginer, Yelda
    Kiper, Nural
    Ozen, Seza
    PEDIATRIC PULMONOLOGY, 2022, 57 (09) : 2267 - 2268
  • [27] Biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor-alpha
    Chambers, RJ
    Marfat, A
    Cheng, JB
    Cohan, VL
    Damon, DB
    Duplantier, AJ
    Hibbs, TA
    Jenkinson, TH
    Johnson, KL
    Kraus, KG
    Pettipher, ER
    Salter, ED
    Shirley, JT
    Umland, JP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (06) : 739 - 744
  • [28] Efficacy of iron supplementation in patients with inflammatory bowel disease treated with anti-tumor necrosis factor-alpha agents
    Kim, Su Young
    An, Sejin
    Park, Dong Kyun
    Kwon, Kwang An
    Kim, Kyoung Oh
    Chung, Jun-Won
    Kim, Jung Ho
    Kim, Yoon Jae
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [29] Role of Tumor Necrosis Factor-Alpha (C-863A) Polymorphism in Pathogenesis of Inflammatory Bowel Disease in Northern India
    Dinesh K. Ahirwar
    Pravin Kesarwani
    Ranjana Singh
    Uday Chand Ghoshal
    Rama Devi Mittal
    Journal of Gastrointestinal Cancer, 2012, 43 (2) : 196 - 204
  • [30] Liver Diseases Associated with Anti-Tumor Necrosis Factor-alpha (TNF-α) Use for Inflammatory Bowel Disease
    Coffin, Carla S.
    Fraser, Hughie F.
    Panaccione, Remo
    Ghosh, Subrata
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) : 479 - 484
12345